Colgate-Palmolive Company (CL) Shares Sold by Dubuque Bank & Trust Co.
Dubuque Bank & Trust Co. reduced its position in shares of Colgate-Palmolive Company (NYSE:CL) by 60.4% during the second quarter, Holdings Channel reports. The firm owned 2,411 shares of the company’s stock after selling 3,685 shares during the period. Dubuque Bank & Trust Co.’s holdings in Colgate-Palmolive were worth $178,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Blue Chip Partners Inc. boosted its position in shares of Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares during the period. Alpha Windward LLC boosted its position in shares of Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock worth $207,000 after buying an additional 18 shares during the period. Northstar Group Inc. boosted its position in shares of Colgate-Palmolive by 0.4% in the first quarter. Northstar Group Inc. now owns 4,850 shares of the company’s stock worth $356,000 after buying an additional 20 shares during the period. M Holdings Securities Inc. boosted its position in shares of Colgate-Palmolive by 0.4% in the first quarter. M Holdings Securities Inc. now owns 5,366 shares of the company’s stock worth $393,000 after buying an additional 21 shares during the period. Finally, Capital Investment Advisors LLC boosted its position in shares of Colgate-Palmolive by 0.3% in the second quarter. Capital Investment Advisors LLC now owns 8,318 shares of the company’s stock worth $617,000 after buying an additional 27 shares during the period. 73.85% of the stock is owned by institutional investors.
Shares of Colgate-Palmolive Company (CL) traded down 0.41% during mid-day trading on Friday, reaching $71.26. 2,023,502 shares of the company were exchanged. The company’s 50 day moving average price is $72.84 and its 200 day moving average price is $72.74. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The firm has a market capitalization of $62.77 billion, a PE ratio of 26.48 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a net margin of 15.83% and a return on equity of 3,121.95%. The business had revenue of $3.83 billion for the quarter, compared to analyst estimates of $3.89 billion. During the same quarter in the previous year, the business earned $0.70 earnings per share. The firm’s revenue was down .5% compared to the same quarter last year. Equities analysts anticipate that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be issued a dividend of $0.40 per share. The ex-dividend date is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.25%. Colgate-Palmolive’s dividend payout ratio is currently 59.48%.
A number of brokerages have issued reports on CL. UBS AG reaffirmed a “neutral” rating and issued a $78.00 target price (down from $79.00) on shares of Colgate-Palmolive in a report on Tuesday, May 2nd. Royal Bank Of Canada reiterated a “hold” rating and issued a $74.00 price target on shares of Colgate-Palmolive in a research report on Monday, April 24th. Jefferies Group LLC assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, April 18th. They issued a “hold” rating and a $78.00 price target on the stock. BidaskClub lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research report on Saturday, June 24th. Finally, Wells Fargo & Company reiterated a “market perform” rating on shares of Colgate-Palmolive in a research report on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $75.82.
In other news, insider Patricia Verduin sold 3,833 shares of the business’s stock in a transaction that occurred on Monday, July 17th. The shares were sold at an average price of $72.41, for a total transaction of $277,547.53. Following the sale, the insider now owns 53,022 shares in the company, valued at $3,839,323.02. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Justin Skala sold 74,374 shares of the business’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total transaction of $5,392,858.74. Following the sale, the chief operating officer now owns 97,177 shares in the company, valued at approximately $7,046,304.27. The disclosure for this sale can be found here. Insiders have sold 203,969 shares of company stock worth $14,711,068 in the last 90 days. 1.02% of the stock is owned by company insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.